Recent trends in the utilization of molecular breast imaging in the United States
MBI is consistently underutilized during the study period despite its accuracy, affordability, and safety for diagnosing breast cancer.
Authors
- Michelle V. Lee (ORCID: https://orcid.org/0000-0003-3733-893X)
- Debbie L. Bennett (ORCID: https://orcid.org/0000-0003-1898-0361)
- Dustin Stwalley (ORCID: https://orcid.org/0000-0002-6427-0590)
- Sherwin Chiu (ORCID: https://orcid.org/0000-0001-9557-5752)
- Heather V. Garrett (ORCID: https://orcid.org/0000-0002-7176-9744)
- Lin Gu (ORCID: https://orcid.org/0000-0002-9189-2619)
- S. J. Singer
- Ria Dave
Institutions
- Washington University in St. Louis (US)
- Mallinckrodt (United States) (US)
- University of Missouri–Kansas City (US)
Publication Details
- Journal
- Clinical Imaging
- Published
- 2026-01-16
- DOI
- https://doi.org/10.1016/j.clinimag.2026.110728
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- International Business Machines Corporation
- Institute of Clinical and Translational Sciences
- National Institutes of Health
- Agency for Healthcare Research and Quality
- National Center for Advancing Translational Sciences